Registro Campania Salute Network on Hypertension

Hypertension; Heart Disease, Hypertensive Clinical Trial

— RCSN  

Official title:

Registro Campania Salute Network for the Treatment of Hypertension and Correlated Diseases

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT02211365
• Other study ID #: 16/14
• Status: Recruiting
• Start date: February 2014
• Est. completion date: April 2030

Study information

• Verified date: September 2023
• Source: Federico II University
• Contact: Bruno Trimarco, MD
• Phone: +390817462250
• Email: trimarco[@]unina.it
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The Registro Campania Salute Network (RCSN) is a prospective registry aimed at improving the management of essential hypertension by integrating the activity of general practitioners (GPs) with that of the hypertension specialist. It involves selected GPs homogeneously allocated in the regional area, and the Hypertension Clinic of the Federico II University in Naples, which served as co-ordinating centre. Through the RCSN system it is possible to store clinical data detected at each visit between the peripheral units and the co-ordinating centre and to support scientific analysis of the dataset.

Description:

The patients will be followed over a period of twenty years and all clinical data will be recorded in order to investigate the role of hypertension and correlated disease on this patient population

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 10000
• Est. completion date: April 2030
• Est. primary completion date: March 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 85 Years

Eligibility

Inclusion Criteria:

-Hypertension

• 18 years old

Exclusion Criteria:

• Refused to sign informed consent

Related Conditions & MeSH terms

• Heart Diseases
• Hypertension
• Hypertension; Heart Disease, Hypertensive

Locations

Country	Name	City	State
Italy	Department od advanced biomedical sciences, Università degli studi di Napoli Federico II, Via sergio Pansini 5	Napoli

Sponsors (1)

Lead Sponsor	Collaborator
Federico II University

Country where clinical trial is conducted

Italy, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	MACCE	Major adverse cardiac and cerebrovascular events	every year up to 20 years